A missense mutation in AP2M1 impairs CME and causes epileptic and developmental encephalopathy [7], and the CNV of AP2M1 may contribute to the risk of autism spectrum disorders [35]. This evidence concerns the gene AP2M1 and autism spectrum disorder.